Establishes a prognostic model for HCC that reveals significant associations with immune features, suggesting implications for personalized treatment.
In this study, we established a prognostic risk model for HCC with strong predictive performance. Risk-based stratification revealed its associations with immune infiltration, immunotherapy response, and drug sensitivity. These findings offer new insights into survival prediction and clinical features in patients with HCC.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: